Sensitivity of bacteriophage Mu-1 development to rifampicin and streptolydigin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001433:Bacteriolysis / Q000187:drug effects; D003090:Coliphages / Q000187:drug effects*; D008242:Lysogeny / Q000187:drug effects; D011714:Pyrans / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects
D000900:Anti-Bacterial Agents; D011714:Pyrans; D011760:Pyrrolidinones; D012293:Rifampin